General Information of Drug (ID: DM37BAA)

Drug Name
PDS0101
Indication
Disease Entry ICD 11 Status REF
Head and neck cancer 2D42 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D31NIC

References

1 ClinicalTrials.gov (NCT04260126) Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (VERSATILE002). U.S. National Institutes of Health.